United States: October 2016 IPO Market Review

Last Updated: December 1 2016
Article by David A. Westenberg

The IPO market produced 19 IPOs in October, representing the highest monthly figure since the 33 IPOs in June 2015. Over the first ten months of 2016, there have been 88 IPOs—36% below the 138 IPOs over the corresponding period of 2015.

Buoyed by the largest IPO of the year, the $1.41 billion IPO by China's ZTO Express, gross proceeds for October were $4.57 billion, the highest monthly figure since October 2015. The first 10 months of 2016 have produced gross proceeds of $16.30 billion, 30% below the $23.34 billion raised over the first 10 months of 2015 and the third lowest annual tally over the past 12 years.

IPOs by emerging growth companies (EGCs) have accounted for 83% of the year's IPOs, down from 93% in 2015. Since enactment of the JOBS Act in 2012, 85% of all IPOs have been by EGCs.

October produced six IPOs by life sciences companies. Over the first 10 months of 2016, there have been 37 IPOs by life sciences companies, representing 42% of the year's total compared to 47% in 2015 and 40% in 2014. In absolute terms, however, the 2016 life sciences IPO count falls far short of the 98 life sciences IPOs in 2014 and 72 in 2015.

The median offering size for all IPOs over the first 10 months of 2016 was $94.5 million, or 3% above the $91.7 million for all IPOs in 2015, while the median offering size for life sciences company IPOs was $60.5 million, less than half of the $130.0 million figure for non-life sciences companies.

Year-to-date, the median offering size for IPOs by EGCs was $80.1 million, compared to $346.5 million for non-EGCs (the lowest annual figures since enactment of the JOBS Act). From 2012 to 2015, the median EGC IPO offering size was $87.0 million, compared to $425.5 million for non-EGCs.

The median annual revenue of IPO companies through the first 10 months of 2016 was $66.5 million, or 76% above the $37.8 million median figure for 2015, but well below the $92.7 million median figure for the five-year period from 2010 through 2014. The median life sciences IPO company in the first 10 months of 2016 had annual revenue of $4.0 million, compared to $214.3 million for all other IPO companies (the highest annual figure since 2009).

Only four IPO companies in October were profitable. Over the first 10 months of 2016, 35% of IPO companies have been profitable, compared to 30% in 2015 and 36% in 2014, but well below the 54% figure that prevailed over the five-year period preceding 2014. Excluding life sciences companies, 53% of IPO companies over the first 10 months of 2016 have been profitable, just shy of the 55% over the five-year period preceding 2016.

Following September, a month where all the month's new offerings posted a first-day gain, only 10 October IPOs posted a first-day gain. Two of the month's new offering were flat in first-day trading while the remaining seven were "broken" (IPOs whose stock closes below the offering price on their first day).

Through October 31, the average 2016 IPO has produced a first-day gain of 13%, compared to 16% in 2015 and the lowest annual figure since 2010. The average 2016 life sciences IPO company has gained 8% in first-day trading, compared to 17% for all other 2016 IPO companies.

Over the first 10 months of 2016, 24% of IPOs have been "broken". This figure is down from 26% in 2015 and 27% in 2014.

At October month-end, the average 2016 IPO company was trading 21% above its offering price. At October 31, 38% of 2016 IPO companies were trading below their offering price, while 35% were trading at least 25% above their offering price. The average 2016 life sciences company ended October up 19% from its offering price, while the average non-life sciences IPO company ended the month 23% above its offering price.

IPO activity in October consisted of offerings by the following companies listed in the order they came to market:

  • Advanced Disposal Services, a leading integrated provider of non-hazardous solid waste collection, transfer, recycling and disposal services operating primarily in secondary markets or under exclusive arrangements with municipalities, priced at the low end of the range and produced a first-day gain of 11%.
  • AquaVenture Holdings, a multinational provider of Water-as-a-Service solutions that provides its customers with a reliable and cost-effective source of clean drinking and process water primarily under long-term contracts that minimize capital investment by the customer, priced at the low end of the range and ended its first day of trading up 22% from its offering price.
  • Coupa Software, the leading provider of a unified, cloud-based spend management platform that connects more than 460 organizations with more than two million suppliers globally, priced an upsized IPO at the high end of an upwardly revised price range and gained 85% in first-day trading—the third best first-day gain of the year.
  • Obalon Therapeutics, a commercial-stage medical device company focused on developing and commercializing innovative medical devices to treat obese and overweight people by facilitating weight loss, priced within the range and was flat in first-day trading.
  • Camping World Holdings, a provider of a comprehensive portfolio of services, protection plans, products and resources for recreational vehicle enthusiasts, priced at the midpoint of the range and produced a 2% first-day gain.
  • Everspin Technologies, the leading provider of MRAM solutions that offer the persistence of non-volatile memory, a type of memory that retains information even in the absence of power, with the speed and endurance of random access memory (RAM), and enables the protection of mission critical data particularly in the event of power interruption or failure, priced an upsized IPO below the range and eked out a two cent gain in first-day trading.
  • Azure Power Global, a seller of solar power in India on long-term fixed price contracts to its customers, at prices which in many cases are at or below prevailing alternatives for these customers, priced below the range and ended its first day of trading down 19% from its offering price.
  • AzurRx BioPharma, a company engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders, priced a downsized IPO below the original range and ended its first trading day down less than 1% from its offering price.
  • Extraction Oil & Gas, an independent oil and gas company focused on the acquisition, development and production of oil, natural gas and natural gas liquid reserves in the Rocky Mountains, primarily in the Wattenberg Field of the Denver-Julesburg Basin of Colorado, priced above the range and gained 15% on its first day of trading.
  • Mammoth Energy Services, an integrated, growth-oriented oilfield service company serving companies engaged in the exploration and development of North American onshore unconventional oil and natural gas reserves, priced at the low end of the range and declined 12% in first-day trading.
  • CRISPR Therapeutics, a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics, priced below the range and ended its first day of trading with a gain of less than 1%.
  • Forterra, a leading manufacturer of pipe and precast products by sales volume in the United States and Eastern Canada for a variety of water-related infrastructure applications, including water transmission, distribution and drainage, priced below the range and ended its first trading day down 8% from its offering price.
  • iRhythm Technologies, a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining its wearable biosensing technology with cloud-based data analytics and machine-learning capabilities, priced an upsized IPO above the range and produced a 53% first-day gain.
  • Ra Pharmaceuticals, a clinical-stage biopharmaceutical company using its proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, priced an upsized IPOs at the midpoint of the range and was flat in first-day trading.
  • Myovant Sciences, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women's health diseases and other endocrine-related disorders, priced an upsized IPO above the range and ended its first day of trading 12% below its offering price.
  • ZTO Express, a leading express delivery company in China and one of the largest express delivery companies globally, in terms of total parcel volume in 2015, priced above the range and declined 15% in first-day trading.
  • Acushnet Holdings, a global leader in the design, development, manufacture and distribution of performance-driven golf products, priced below the range and produced a 6% first-day gain.
  • BlackLine, a creator of a comprehensive cloud-based software platform designed to transform and modernize accounting and finance operations for organizations of all types and sizes, priced at the high end of an upwardly revised price range and ended its first day of trading 39% above its offering price.
  • Quantenna Communications, a leader in the design, development and marketing of advanced high-speed wireless communication solutions enabling wireless local area networking, priced at the high end of the range and ended its first trading day down 3% from its offering price.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.